|
|
|
Substance Name: Nintedanib [USAN:INN]
RN: 656247-17-5
UNII: G6HRD2P839
InChIKey: XZXHXSATPCNXJR-ZIADKAODSA-N
Notes
- Boehringer Ingelheim's triple kinase inhibitor blocking VEGFR, PDGFR and FGFR.
- NLM: Boehringer Ingelheims triple kinase inhibitor blocking VEGFR, PDGFR and FGFR.
NCI: An orally bioavailable, indolinone-derived, receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Multitargeted tyrosine kinase inhibitor BIBF 1120 selectively binds to and inhibits vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet-derived growth factor receptor (PDGFR) tyrosine kinases, which may result in the induction of endothelial cell apoptosis; a reduction in tumor vasculature; and the inhibition of tumor cell proliferation and migration. In addition, this agent also inhibits members of the Src family of tyrosine kinases, including Src, Lck, Lyn, and FLT-3 (fms-like tyrosine kinase 3). VEGFR, FGFR and PDGFR RTKs play key roles in tumor angiogenesis. NCI Thesaurus)
Molecular Formula
- C31-H33-N5-O4
Molecular Weight
- 539.6327
Classification Codes
- Antineoplastic Agents
- Enzyme Inhibitors
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Nintedanib [USAN:INN]
Synonyms
- BIBF 1120
- BIBF-1120
- BIBF1120
- HSDB 8339
- Intedanib
- Methyl (3Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylidene)-2-oxo-2,3-dihydro-1h-indole-6-carboxylate
- Nintedanib
- OFEV
- UNII-G6HRD2P839
- Vargatef
Registry Numbers
CAS Registry Number
- 656247-17-5
FDA UNII
- G6HRD2P839
Other Registry Number
- 928326-83-4
System Generated Number
- 0656247175